Abstract. Hypothalamic orexin neurons are known to regulate sleep/wake stability, feeding behavior, emotions, autonomic nerve activity, and whole-body energy metabolism. In addition, emerging evidence indicates that orexin contributes to central regulation of glucose homeostasis. Intriguingly, central administration of orexin is reported to cause blood glucoseelevating effect or blood glucose-lowering effect in rodents, depending on the experimental conditions. Here we reviewed the recent reports regarding the mode and mechanism of actions of orexin on these two opposing effects, and discuss the functional significance for the maintenance of glucose homeostasis. The fact that orexin exhibits biphasic effects on autonomic nerve activity and lipolysis suggests that orexin dually regulates the glucose appearance. In fact, orexin neurons are activated not only depending on the demand for glucose but also according to a circadian rhythm in the suprachiasmatic nucleus. The excited orexin neurons appear to alter the sympathetic or parasympathetic outflow to the periphery, and modulate the glucose production and utilization. Furthermore, deficiency of orexin action, particularly reduction of orexin 2 receptor-signaling, disrupts the mechanism for protection against insulin resistance associated with aging or induced by chronic high fat feeding in mice. Taken together, hypothalamic orexin system may manage multiple tasks to coordinate the interconnection among the arousal, feeding, circadian, and glucose homeostasis pathways.
Orexin A and B (also known as hypocretin 1 and 2) are a pair of neuropeptides generated from preproorexin [1] . Orexin-producing neurons are located in the lateral hypothalamic area (LHA), perifornical area (PF), and posterior hypothalamus [2] . The orexin actions are mediated by two G-protein-coupled receptors, orexin-1 receptor (OX1R) and orexin-2 receptor (OX2R) differentially distributed in brain [3] . Within the hypothalamus, OX1R mRNA is most abundant in the ventromedial hypothalamic nucleus (VMH), whereas OX2R is highly expressed in the tuberomammillary nucleus, paraventricular nucleus, arcuate nucleus (ARC), and LHA including PF [4, 5] . Orexin neurons are known to play crucial roles in the regulation of sleep/wake cycle and energy homeostasis ( Fig.  1 ) [2, 6] . In fact, orexin neurons can directly sense the nutritional status by responding to peripheral metabolic signals, such as glucose, leptin, and ghrelin [7] [8] [9] .
The expression of prepro-orexin mRNA is enhanced when blood glucose levels are low, and vice versa [6, 10] . On the other hand, orexin deficiency causes narcolepsy in human, which is accompanied by increased risk of obesity and type 2 diabetes [11] , and both prepro-orexin knockout mice and orexin neuron-ablated mice exhibit narcoleptic behavioural arrest and lateonset obesity, despite decrease in food intake [12] [13] [14] . Thus, orexin is regarded as an essential factor linking energy status to arousal level [15] .
Hypothalamus is the most important site for the central regulation of glucose homeostasis, where multiple hormones and neuropeptides cooperate to produce autonomic outflow to the peripheral tissues, such as liver and skeletal muscle [16] [17] [18] . However, it has long been unclear what molecules are responsible for integration of the complicated metabolic signals arisen at the hypothalamus. Emerging evidence indicates that orexin not only senses peripheral metabolic signals but also controls glucose production and utilization in the peripheral tissues via the autonomic nervous system [18, 19] . These findings open up the possibility that orexin functions as a master regulator to coordi-neurons in the ARC are glucose-excited [20, 22] .
In GE neurons, there are at least two sugar-sensing pathways, either dependent on or independent of cytosolic glucose metabolism. The metabolic glucosensing is considered to involve glucokinase-dependent metabolism of glucose to ATP, which increases the neural activity by closing K ATP channels, whereas the nonmetabolic glucosensing is mediated by electrogenic sodium-glucose cotransporter (SGLT) [21] .
The sugar sensing of orexin neurons, a major class of GI neurons, is metabolism-independent, since the glucose response is unaffected by glucokinase inhibitors, and mimicked by a non-metabolizable glucose analog 2-deoxyglucose [23] , although the precise mechanisms, particularly the functional molecules relevant to glucose-induced inhibition, have not yet been clarified [18] . Orexin neurons are not inhibited by L-glucose, galactose, α-methyl-D-glucoside, or fructose, whereas GE neurons can sense galactose [23] . More recently, it has been proposed that orexin neurons function as a "conditional glucosensor," because the electrical activnate the central and peripheral hormonal actions for the maintenance of glucose homeostasis. In this review, we focused on recent findings about the role of hypothalamic orexin system in the regulation of whole-body glucose and energy homeostasis through the nutrient sensing and the interaction with arousal, feeding, autonomic, and circadian pathways.
nutrient sensing by orexin neuron
Sugar-sensing neurons exist in restricted brain regions, such as hypothalamus and brain stem, and they are classified into two groups, namely glucose-excited (GE) neurons and glucose-inhibited (GI) neurons, in terms of the mode of response to extracellular glucose changes within physiological cerebrospinal fluid (CSF) range [20, 21] . For example, orexin neurons in the LHA and neuropeptide Y (NPY)/agouti-related peptide (AgRP) neurons in the ARC are glucose-inhibited, whereas melanin-concentrating hormone (MCH) neurons in LHA and proopiomelanocortin (POMC)
Fig. 1 Physiological functions of hypothalamic orexin system
Orexin A and orexin B are neuropeptides generated from a common precursor peptide, prepro-orexin. Closed circles indicate identical amino acid sequence between orexin A and orexin B. Only orexin A possesses disulfide bonds stabilizing the tertiary structure. Orexin A is a high-affinity ligand for both orexin 1 receptor (OX1R) and orexin 2 receptor (OX2R), whereas orexin B is a specific high-affinity ligand for OX2R. The orexin system plays important roles in the regulation of arousal, feeding behavior, autonomic nervous system, reward system, and glucose/energy homeostasis.
ity of orexin neurons is more potently inhibited by glucose when intracellular energy levels (i.e., cytosolic levels of pyruvate, lactate, or ATP) are low, whereas high energy levels attenuate the glucose response in orexin neurons [24] . Another important aspect of sugar sensing in orexin neurons can arise from the "adaptive response" to glucose. Electrophysiological recordings in mouse brain slices demonstrated approximately 70% of orexin neurons exhibit time-dependent recovery from inhibition by glucose via adaptive closure of leak-like K + channels [25] . This adaptation seems to provide great advantage to orexin neurons, because the neurons could recognize the change in glucose levels by filtering out the basal glucose levels, and also maintain their excitability at any environmental glucose level. That may help to avoid the occurrence of narcoleptic sleep attacks after meal. In addition, the residual orexin neurons exhibiting non-adaptive glucosensing may also play a crucial role in the detection of the absolute levels of glucose, and contribute to maintain energy homeostasis [25] .
Orexin neurons further display unique sugar sensing in vivo. The consumption of sweet-tasting solution, such as saccharin and sucrose, was increased by intracerebroventricular (i.c.v.) administration of orexin A into rats [26, 27] . Moreover, sucrose intake of preproorexin knockout mice was significantly less than wildtype mice [28] . These results indicate that the hypothalamic orexin system promotes the consumption of sweet-tasting nutrients, which might be beneficial for survival with high probability.
In contrast to the glucose inhibition, amino acids stimulate the electrical activity of orexin neurons through inhibition of K ATP channels and activation of system-A amino acid transporter that preferentially transports nonessential amino acids [29] . Indeed, nonessential amino acids are more potent in activating orexin neurons than essential amino acids. Moreover, the glucose inhibition of orexin neurons was suppressed by the amino acids. Such unique amino acidsensing of orexin neurons may be useful to monitor the circulating amino acid levels, and to promote the food intake upon deficiency of essential amino acid, independently of circulating glucose levels. The third major nutrient, fatty acid, does not affect the activity of orexin neurons. Therefore, prolonged consumption of unbalanced diet, such as carbohydrate-rich or protein-rich meals, may affect whole-body energy balance through the modification of nutrition-sensing of orexin neurons [29] . Taken together, orexin neurons greatly contribute to the nutrient sensing, which is important as the first step of glucose homeostasis regulation.
regulation of glucose production and utilization by orexin
A growing body of evidence indicates that orexin neuronal system has a crucial role in the regulation of glucose homeostasis [18, 19] . However, the actions of orexin are not necessarily simple, because orexin appears to exert opposing effects probably depending on the experimental conditions. One type of action is the blood glucose-elevating effect, and the other is the blood glucose-lowering effect. We describe the current knowledge of orexin action on glucose homeostasis, and discuss its potential significance in the following sections.
The blood glucose-elevating effect of orexin
A bolus subcutaneous injection of orexin A (1 nmol) resulted in an increase in blood glucose and insulin levels in rats under non-fasting condition [30] . Similarly, infusion of orexin A (15 nmol) into the third cerebroventricle increased blood glucose and insulin levels, body temperature, and ambulation, without affecting uncoupling protein 1 (UCP1) expression in brown adipose tissue (BAT) under non-fasting and unanesthetized condition [31] . In conscious rabbits, i.c.v. injection of orexin-A (100 pmol) elicited increases in mean arterial pressure, renal sympathetic nerve activity, plasma epinephrine and glucose concentrations under non-fasting condition [32] . Moreover, Yi et al. have recently reported that a continuous i.c.v. infusion of orexin A (1 mmol/L, 5 μL/h) into rats fasted for 5 h caused an increase in plasma glucose levels, and prevented a daytime decrease of endogenous hepatic glucose production (EGP) [33] . Hepatic sympathetic, but not parasympathetic, denervation blocked the orexininduced apparent enhancement of EGP. Moreover, when the γ-aminobutyric acid (GABA A ) receptor antagonist bicuculline was administered in the PF to activate orexin neurons, basal EGP was increased, and insulin-mediated suppression of EGP was attenuated, but the insulin-induced glucose disposal was enhanced. These results indicate that central action of orexin stimulates sympathetic outflow to the periphery, leading to the promotion of EGP in the liver and glucose uptake in the skeletal muscle [33] . These actions of orexin rons, enhances glucose uptake in the skeletal muscle, and promotes insulin-induced glucose uptake and glycogen synthesis in muscle, but not in white adipose tissue. These effects of orexin are mediated by activation of the sympathetic nervous system in association with β 2 -adrenergic receptor signaling in both myocytes and nonmyocyte cells of skeletal muscle. Furthermore, Ramadori et al. investigated the mechanism by which VMH neurons govern glucose homeostasis, using mice lacking a metabolic sensor, the NAD + -dependent deacetylase SIRT1, in SF1 VMH neurons (Sf1-Cre;Sirt1 loxP/loxP mice) [39] . When fed on a high calorie diet (HC), Sf1-Cre;Sirt1 loxP/loxP mice displayed greater weight gain, reduced energy expenditure, and leptin resistance, compared to control mice. Moreover, the HC-fed mutant mice showed hyperinsulinemia, glucose intolerance, and insulin resistance even before showing severe obesity. Interestingly, a continuous i.c.v. administration of orexin A (0.5 nmol/ day) improved hyperglycemia and hyperinsulinemia in the control mice, but could not exert any ameliorating effect in the mutant mice under the HC-fed condition. These results suggest that VMH is a major site of action of orexin A for the regulation of muscle glucose utilization. However, the role of endogenous orexin in the central regulation of hepatic glucose homeostasis and the implicated receptor subtypes remain to be clarified.
From the technical point of view, it is of note that mice used in laboratory experiments often show elevated resting sympathetic outflow because of cool ambient temperature and caloric challenges [40] . In particular, short-term fasting (about 1-2 h) does stimulate the sympathetic outflow, although overnight fasting evokes marked reduction of sympathetic tone [41] . Since orexin seems to modulate glucose metabolism via the fine-tuning of autonomic balance, different resting autonomic tones in different experimental settings might be, at least partly, account for the apparently opposing effects of orexin on glucose metabolism.
To reveal the influence of long-term deficiency of orexin on glucose homeostasis, we investigated the changes in insulin sensitivity during aging in prepro-orexin knockout mice [42] . Young adult (2-to-3-month-old) prepro-orexin knockout mice showed the disarrangement of insulin signaling through Akt phosphorylation in the hypothalamus, although no apparent abnormality in metabolic parameters was detected at this age. On the other hand, middle-aged (9-monthold) prepro-orexin knockout mice showed hyperinseem to be reasonable in terms of survival in starvation, because when metabolic fuel levels are low, hypothalamic orexin neurons can be activated to supply the energy to muscle via hepatic glucose production, and support searching for food.
The blood glucose-lowering effect of orexin
We initially found that intravenous administration of orexin A (0.01-1 nmol/kg) causes the reduction of fasting blood glucose levels in normal mice and streptozotocin-induced diabetic mice without changing serum insulin concentrations [34] . Similar effects were induced by i.c.v. injection of orexin A at a low dose (2 fmol). Interestingly, the blood glucose-lowering effects of orexin A were not observed under the fed conditions [34] . In oral glucose tolerance test using rats fasted overnight, blood glucose levels were decreased by pretreatment with intraperitoneal injection of orexin A (55 μg/kg) [35] . Transgenic orexin overexpression in mice (CAG/orexin mice) showed normal blood glucose levels with lower insulin and leptin concentrations than wild-type mice on a standard diet [36] . In addition, high fat diet-induced obesity and glucose intolerance were decreased in CAG/orexin mice compared to wildtype mice. These improving effects were disappeared in the CAG/orexin mice crossed to mice lacking OX2R (OX2R-/-mice) but not crossed to OX1R-/-mice. Furthermore, a continuous i.c.v. infusion of an OX2R selective agonist suppressed the diet-induce obesity in wild-type mice, but did not affect the weight gain in leptin-deficient ob/ob mice. Thus, orexin appears to improve the sensitivity to leptin and insulin by an OX2R-dependent mechanism [36] .
In contrast, OX1R signaling appears to induce some detrimental effects on glucose metabolism under obesity-related conditions. In mice fed on a high fat diet, OX1R deficiency ameliorates hyperglycemia and hyperinsulinemia without affecting body weight [36] . In obese ob/ob mice, an OX1R antagonist SB334867A reduces food intake, body weight gain, fasting blood glucose levels and plasma insulin levels, and increases metabolic rate [37] . These provide a novel insight into the anti-obesity and anti-diabetic drug discovery.
Recently, to understand the mechanism by which central action of orexin regulates peripheral glucose metabolism, Shiuchi et al. investigated the changes in glucose uptake in peripheral tissues after the injection of orexin A (5 pmol) into the VMH of mice and rats [38] . Orexin A directly activates the VMH neu-neurons in the intermediolateral column of the spinal cord (IML) that project to the liver and promote the glucose production [45] [46] [47] . In addition, orexin fibers are distributed throughout the rat brainstem including dorsal motor nucleus of vagus (DMNV) neurons and nucleus of the solitary tract (NTS) [48, 49] . Orexin A and B directly depolarize the DMNV neurons, the major source of parasympathetic innervation to the peripheral tissues including liver [50] . It is therefore anticipated that glucose metabolism is dually regulated by orexin system through the changes in sympathetic and parasympathetic balance (Fig. 2) . Indeed, lowdose of orexin A (10 ng i.c.v.) lowers lipolysis by suppressing sympathetic nerve activity (probably through parasympathetic innervation, [51] ), whereas high-dose of orexin A (1000 ng i.c.v.) promotes lipolysis through facilitation of the sympathetic nervous system [52] . Moreover, low-dose of orexin A (10 ng i.v., 0.01 ng i.c.v., or 5 pmol into NTS) evokes a cardiovascular suppressive effect, whereas high-dose of orexin A (1000 ng i.v., 10 ng i.c.v., or >20 pmol into NTS) conversely induces the cardiovascular excitatory effects [53, 54] .
The circadian clock has been reported to regulate sulinemia and impairment of glucose tolerance and insulin resistance. Insulin signaling through Akt pathway was severely impaired in the hypothalamus, liver and skeletal muscle of prepro-orexin knockout mice. Female prepro-orexin knockout mice with advancing age also exhibited hyperleptinemia. Thus, orexin deficiency causes the progressive impairment of insulin action in the hypothalamus and peripheral tissues. We therefore suggest that orexin is a crucial factor to prevent the development of insulin resistance with aging.
Involvement of orexin in rise and fall of blood glucose levels with circadian rhythm
The functions of key organs involved in peripheral glucose metabolism are dually regulated by the sympathetic and parasympathetic nervous systems [17] . Stimulation of the LHA increases the activity of hepatic vagal nerve, whereas stimulation of the VMH produces a strong inhibition of vagal nerve activity in anesthetized rats [43] . An anatomical analysis using retrograde neural tracer demonstrated that orexin neurons in the LHA project to liver and adipose tissue [44] . Orexin fibers impinge upon sympathetic preganglionic reported the functional significance of orexin in adipocytes. Skrzypski et al. performed in vitro study using 3T3-L1 adipocytes and isolated primary rat adipocytes, and demonstrated that orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion [67] . These effects were mediated by PI3K and PPARγ2, suggesting that orexin acts as an insulin sensitizer in white adipose tissue. Sellayah et al. found that obesity in prepro-orexin knockout mice on a high fat diet is associated with impaired BAT thermogenesis, and that the failure of thermogenesis in prepro-orexin knockout mice is due to inability of brown preadipocytes to differentiate [68] . Moreover, in cultured brown preadipocyte cells, orexin A promotes the BAT differentiation via OX1R that activates p38 mitogen activated protein kinase and bone morphogenetic protein receptor-1a (BMPR1A)-dependent Smad1/5 signaling [68] . Central administration of orexin-A did not affect the expression levels of UCP1, a thermogenesis-regulating factor, in the BAT of rats [31, 69] . However, it remains to be clarified whether central action of orexin involves the regulation of adipose tissue differentiation and functions through the autonomic nervous system. In the LHA, majority of neurons possessing functional leptin receptor (LepRb) contains neurotensin, which are connected with the local orexin neurons and mesolimbic dopaminergic system [70] . Mice null for LepRb specifically in neurotensin neurons (NtsLepRbKO mice) demonstrated modestly increased food intake, early onset of obesity, and decreased locomotor activity [70] . It is therefore suggested that leptin action on neurotensin-containing neurons in the LHA contributes to the control of energy balance through the activation of orexin neurons and mesolimbic dopaminergic system.
Diet restriction efficiently increases the protein levels of NAD + -dependent deacetylase SIRT1 and induces neural activation in the dorsomedial and lateral hypothalamic nuclei [71] . Brain-specific SIRT1 transgenic mice (BRASTO mice) exhibited enhanced neural activity in the DMH and LH, increased body temperature, and increased physical activity in response to long-term fasting (48 h), whereas no such responses were observed in Sirt1-deficient mice. Importantly, diet restriction induces the enhancement of OX2R expression specifically in the DMH and LH in a SIRT1 expression-dependent manner, and the luciferase assay and chromatin-immunoprecipitation assay demonstrate that SIRT1 directly enhances the OX2R promotor activthe glucose and lipid metabolism in the liver and other peripheral tissues [55] [56] [57] . Orexin neurons receive dense inputs from preoptic area, dorsomedial nucleus, posterior hypothalamus, lateral septum, and bed nucleus of the stria terminalis, suggesting that orexin neurons are influenced by signals regulating sleep/wake behavior, appetite, emotions, autonomic tone, and circadian rhythms [58] . In particular, PF orexin neurons are innervated by both glutamatergic and GABAergic projections from the suprachiasmatic nucleus (SCN), the master circadian clock [46] . Indeed, orexin neurons in the PF and dorsomedial hypothalamus (DMH) but not LHA exhibit diurnal activity rhythm [59, 60] . The gene expression and CSF content of orexin also display circadian rhythm [61] [62] [63] [64] . It has been reported that the SCN biological clock not only controls the sleep/ wake or feeding/fasting cycle but also regulates daily rhythms in plasma glucose concentrations, mainly due to the changes in hepatic glucose production through sympathetic and parasympathetic nervous system [46] . The rhythmic changes in glucose levels are independent of the daily feeding rhythm or the levels of glucose-regulatory hormones, such as insulin, glucagon, and corticosterone [46] . I.c.v. injection of orexin antagonist completely prevented the endogenous rise in glucose levels at the end of the sleep period, indicating that PF orexin is the main factor to control the daily rhythm in plasma glucose concentrations [47] . Thus, orexin appears to play a pivotal role in the interconnection among biological clock, sleep/wake cycle, and glucose homeostasis. Although orexin A independently exerts blood glucose-elevating and -lowering effects under different experimental conditions, the respective effects may be implicated in the rise and fall of blood glucose levels with circadian rhythm (Fig. 2) . Further studies are required to elucidate the mechanisms how these opposing effects of orexin are adequately coordinated under physiological conditions.
regulation of energy homeostasis by orexin
Evidence indicates that orexin has some peripheral actions to regulate the energy balance and glucose homeostasis (Reviewed by Heinonen et al. [65] ), although their functional significance is far from definitive because circulating levels of orexin are very low, and because no mRNAs for prepro-orexin, OX1R, and OX2R were detected in pancreas, liver, adipose tissue or muscle of rats [66] . Recently, two groups have hypothalamic orexin system deals with multiple tasks to promote and coordinate the interconnection among the arousal, feeding, circadian, and glucose homeostasis pathways.
The incidence of type 2 diabetes is increasing worldwide, and the increasing prevalence with age is the likely explanation for this observation [73] . Also in rats, insulin resistance is shown to occur progressively with age, and this abnormality was attributed to agedependent disruption of the atropine-sensitive (possibly parasympathetic nerve-related) machinery for meal-induced insulin sensitization [74] . Unilateral denervation of the rat liver is more deleterious to maintain the rhythmic liver glucose metabolism than a complete removal of both autonomic branches, indicating the importance of balanced autonomic system in the regulation of glucose homeostasis [75] . Although orexin greatly contributes to the autonomic nervous system regulation [76] , the number of orexin-containing neurons, the neural content of orexin peptide, and CSF orexin A concentration are reduced during aging in rats [64, 77] . Orexin deficiency significantly promotes the age-dependent development of insulin resistance in mice [42] . Therefore, additional investigations on the orexin-mediated mechanisms coordinating intraorgan connections for glucose homeostasis will provide a novel insight into the development of drug to treat age-related metabolic disorders, including type 2 diabetes.
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ity. OX1R is not involved in this process. Therefore, it is likely that the augmentation of OX2R-mediated activation of the DMH and LH neurons leads to the adaptive responses to diet restriction, such as the increased thermogenesis and physical activity [71] .
A forkhead box transcription factor, Foxa2, is intensively expressed in orexin neurons and MCH neurons in the LHA, and its subcellular localization is regulated by insulin [72] . During fasting, Foxa2 binds to the orexin and MCH promoters and stimulates their expression, whereas in the fed state, insulin signaling leads to exclusion of Foxa2 from nucleus and reduced the expression of orexin and MCH. Consistently, NesCre/+;Foxa2T156A flox/flox mice with constitutively-active Foxa2 in the brain exerts increased expression of orexin and MCH, increased food intake, and increased spontaneous activity. Interestingly, the mutant mice also exhibited increased insulin sensitivity in the insulin tolerance test, decreased plasma glucose concentration in the fed state, and decreased plasma insulin concentrations in the fasting state [72] . These results strongly suggest that the LHA orexin neurons as well as MCH neurons play a crucial role in the central regulation of glucose homeostasis by insulin.
Perspectives
In this review, we summarized the functional significance of hypothalamic orexin system in the central regulation of glucose homeostasis. In this system, orexin neurons exquisitely sense the peripheral nutrient status, regulate the balance of autonomic outflow, and control the glucose production and utilization in a peripheral tissue-dependent manner. Given that hypothalamic orexin neurons stimulate both preganglionic sympathetic (IML) and parasympathetic (DMV) neurons [45, 50] , it is plausible that orexin dually regulates glucose homeostasis by changing the autonomic balance (Fig. 2) . Therefore, we would like to suggest that references
